Due to the involvement of TNF-α in the pathogenesis of autoimmune diseases, TNF-α inhibitors have been successfully developed and applied in the clinical treatment of autoimmune diseases such as Crohn’s disease (CD) and RA [27,28]. Here, TNF is linked to Crohn disease.